RT Journal Article
SR Electronic
A1 Rizzo, Toni
T1 Efficacy of Different Doses of Rituximab for the Treatment of RA: Data from the CERERRA Collaboration
JF MD Conference Express
YR 2012
FD SAGE Publications
VO 12
IS 9
SP 11
OP 12
DO 10.1177/155989771209008
UL http://mdc.sagepub.com/content/12/9/11.abstract
AB The approved dose of rituximab for the treatment of rheumatoid arthritis (RA) is 1000 mg × 2, but some data have suggested similar clinical efficacy with rituximab 500 mg × 2. The objective of this analysis was to compare the efficacy of the 2 doses, given as first or second treatment courses. The data for this analysis were obtained from the European Collaborative Registries for the Evaluation of Rituximab in Rheumatoid Arthritis [CERERRA], which includes 10 European registries.